Piritrexim

• Description:

  Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  325.37

• Molecular Formula:

  C17H19N5O2

• Notes:

  Research use only, not for human use.

• Receptor:

  DHFR

• CAS Number:

  72732-56-0